Tcr2 Therapeutics Inc.

MORGAN STANLEY

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

155,390

Value ($000)

233

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	233	0.0%	155,390	3/31/2023
2022 Q4	2/14/2023	46	0.0%	46,395	12/31/2022
2022 Q3	11/14/2022	131	0.0%	73,248	9/30/2022
2022 Q2	10/27/2022	434	0.0%	149,583	6/30/2022
2022 Q1	10/27/2022	794	0.0%	287,402	3/31/2022
2021 Q4	2/14/2022	2,089	0.0%	448,330	12/31/2021
2021 Q3	11/15/2021	1,102	0.0%	129,377	9/30/2021
2021 Q2	8/23/2021	2,570	0.0%	156,580	6/30/2021
2021 Q1	5/17/2021	33	0.0%	1,501	3/31/2021
2020 Q4	2/16/2021	659	0.0%	21,322	12/31/2020
2020 Q3	11/13/2020	78	0.0%	3,845	9/30/2020
2020 Q2	8/14/2020	2,152	0.0%	140,114	6/30/2020
2020 Q1	5/26/2020	50	0.0%	6,484	3/31/2020
2019 Q4	2/14/2020	317	0.0%	22,218	12/31/2019